HIV

Affordable Treatment: Not Letting HIV Define You

HIV is no longer a terminal disease; it is a treatable and manageable condition.

At Aprazer Healthcare, we are committed to ending the HIV epidemic by continuously developing innovative treatments and making them available at the lowest rates.

The Global Access Crisis

Every year, millions of people die of AIDS because of lack of access to essential life–saving medications.
95% of these belong to low-income groups that cannot afford treatment or reside in low-income countries without basic healthcare amenities.

Challenges in HIV/AIDS Treatment

• • High treatment costs: Anti-retroviral therapy is lifelong and constitutes an expensive treatment that most people cannot afford.
• • Limited access: Geographical barriers and poor healthcare facilities and services.
• • Fear of Social Discrimination: Social taboos prevent treatment, prevention, or testing.
• • In compliance to treatment: Missed doses and incomplete treatments cause failures and increase infection risk.
• • Disrupted Global supply chain: Shortages of HIV therapeutics in low-income countries.
• • Other infections: Opportunistic infections invade the weakened immune system.

Aprazer Healthcare: Making a Global Impact through Access to Affordable Medicine

From India to Africa, Aprazer Healthcare is transforming global access to WHO pre qualified ARV medicines at affordable rates.
Through strong distribution and collaboration with partners, organizations, and hospitals, we ensure reach to even the most remote areas.

Our Product Portfolio

Advancing HIV Treatment with Combined Drug Formulations for the ART Regimen:

• • Abakast-L – Abacavir and Lamivudine (NRTI combination).
• • Lamipure-150 – Lamivudine, an NRT inhibitor used for HIV and Hepatitis B.
• • Lopikast – Lopinavir and Ritonavir combination to reduce HIV complications.
• • Temirazor – Tenofovir disoproxil fumarate and emtricitabine combination for prophylaxis treatment.
• • Tudobest-L – Tenofovir Disoproxil Fumarate and Lamivudine to slow HIV replication.
• • Tudobest-LE – Tenofovir Disoproxil Fumarate, Efavirenz, and Lamivudine (NRTI and NNRTI combination).
• • Virarazer – Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz, a highly effective first-line HIV treatment regimen.

We aim to continually reduce the cost of manufacturing and streamline our distribution network to make life-saving medicines accessible to all, wherever they are.

"Building a sustainable future for generations to come."